Bieber, Thomas, Lisa Beck, Andrew Pink, Hidehisa Saeki, Lawrence Eichenfeld, Thomas Werfel, Anders Rosholm, Mads Ropke, and Amy Paller. 2021. ‚ÄúNeutralizing Interleukin-13 Increases Skin Microbial Diversity: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Tralokinumab in Adult Patients With Atopic Dermatitis‚ÄĚ. SKIN The Journal of Cutaneous Medicine 5 (6):s56. https://doi.org/10.25251/skin.5.supp.56.